Updates and trial results from the American Society of Clinical Oncology (ASCO) annual meeting have dominated the headlines over the past couple of weeks, showcasing the latest developments in the hot field of immuno-oncology.

Today’s sector video features a report from BBC News on the results of a clinical trial combining cancer drugs ipilimumab and nivolumab, which was found to shrink tumours in nearly 60% of people with advanced melanoma.

Nivolumab is the second treatment to be given a positive scientific opinion as part of the Early Access to Medicines Scheme, also announced this week.

Do you have a video you would like the sector to see? Contact us.